For updated information about JADPRO Live 2024, please visit JADPROLive.com

CURRENT ISSUE Current Issue Cover
VOL 15 NO 3 • Apr 2024
IN THIS ISSUE

Shaping the Future of Oncology at JADPRO Live 2023

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Staying Abreast of New Biomarkers in Hematology/Oncology

Presented by Andrew Guinigundo,(1) MSN, RN, CNP, ANP-BC, FAPO, and Grace Baek,(2) PharmD, BCOP

2022–2023 Drug Updates in Solid Tumors

Presented by Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP

2022–2023 Drug Updates in Hematologic Malignancies

Presented by Rebecca L. Rezac, PharmD, BCOP

 
Section Seperator

TODAY'S NEWS

Comparative Effectiveness of Acupuncture...

Pain, a debilitating consequence of cancer and its...

Immunotherapy Resistance and Response to...

Researchers may have uncovered the mechanisms behi...

The Lancet Commission on Breast Cancer R...

Investigators have uncovered persistent inequities...

A Pioneering Female Oncologist in Morocc...

Success stories in research, advocacy, and educati...

Cisplatin, Gemcitabine, and IMRT in Loca...

In a phase II trial (NRG Oncology/GOG Study 279) r...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Advanced Practitioners as Allies and Advocates

Advanced practitioners (APs) are a growing proportion of the health-care team...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights More Highlights
Section Seperator

LATEST TWEETS

Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO Twitter Feed.cshtml)

More Tweets More Tweets
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
 
 
Designed by Harborside
Copyright © 2010-2023 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.